EcoDrugPlus

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSOMYG00000000990
Gene Symbol: FGFR2
1 Cross references
213 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSOMYG00000013467
Gene Symbol: FGFR2
1 Cross references
213 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSOMYG00000064424
Gene Symbol: FGFR3
1 Cross references
191 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSOMYG00000011130
Gene Symbol: FLT1
1 Cross references
192 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSOMYG00000066847
Gene Symbol: FLT4
1 Cross references
183 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSOMYG00000016274
Gene Symbol: FLT4
1 Cross references
185 Possible Orthologues:

Folate Receptor Gamma

Ensembl ID : ENSOMYG00000040616
Gene Symbol: FOLR3
2 Cross references
436 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSOMYG00000006788
Gene Symbol: FSHR
2 Cross references
200 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSOMYG00000041527
Gene Symbol: FRK
1 Cross references
156 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSOMYG00000007944
Gene Symbol: FRK
1 Cross references
156 Possible Orthologues:

Galactosidase, Alpha

Ensembl ID : ENSOMYG00000021521
Gene Symbol: GLA
2 Cross references
196 Possible Orthologues:

Galectin 3

Ensembl ID : ENSOMYG00000019978
Gene Symbol: LGALS3
1 Cross references
160 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).